4,088 results on '"Alavi, Abass"'
Search Results
152. Comparison of 18F-sodium fluoride uptake in the whole bone, pelvis, and femoral neck of multiple myeloma patients before and after high-dose therapy and conventional-dose chemotherapy
153. Assessing the effects of body weight on subchondral bone formation with quantitative 18F-sodium fluoride PET
154. 18F-sodium fluoride PET/CT provides prognostic clarity compared to calcium and Framingham risk scoring when addressing whole-heart arterial calcification
155. Assessing the feasibility of NaF-PET/CT versus FDG-PET/CT to detect abdominal aortic calcification or inflammation in rheumatoid arthritis patients
156. 64Cu-DOTATOC PET-CT in Patients with Neuroendocrine Tumors
157. Atherosclerosis imaging with 18F-sodium fluoride PET: state-of-the-art review
158. Incremental value of FDG-PET/CT to monitor treatment response in infectious spondylodiscitis
159. Suboptimal validity of amyloid imaging-based diagnosis and management of Alzheimer’s disease: why it is time to abandon the approach
160. An update on the unparalleled impact of FDG-PET imaging on the day-to-day practice of medicine with emphasis on management of infectious/inflammatory disorders
161. PET Assessment of Immune Effects from Interventional Oncology Procedures
162. The Evolving Role of PET-Based Novel Quantitative Techniques in the Interventional Radiology Procedures of the Liver
163. Evolving Roles of Fluorodeoxyglucose and Sodium Fluoride in Assessment of Multiple Myeloma Patients: Introducing a Novel Method of PET Quantification to Overcome Shortcomings of the Existing Approaches
164. Evolving Role of PET-Based Novel Quantitative Techniques in the Management of Hematological Malignancies
165. Potential and Most Relevant Applications of Total Body PET/CT Imaging
166. Potential Role of PET in Assessing Ventricular Arrhythmias
167. The Potential Role of Total Body PET Imaging in Assessment of Atherosclerosis
168. PET/Computed Tomography Evaluation of Infection of the Heart
169. Evolving Role of PET in Detecting and Characterizing Atherosclerosis
170. Clinical Applications of Positron Emission Tomography in the Evaluation of Spine and Joint Disorders
171. Evolving Role of PET/CT-MRI in Assessing Muscle Disorders
172. In Vivo Molecular Imaging of Musculoskeletal Inflammation and Infection
173. Evolving Role of MR Imaging and PET in Assessing Osteoporosis
174. Metastatic Seeding Attacks Bone Marrow, Not Bone: Rectifying Ongoing Misconceptions
175. Critical role of PET/CT-based novel quantitative techniques for assessing global disease activity in multiple myeloma and other hematological malignancies: why it is time to abandon reliance on examining focal lesions
176. The effect of metal artefact reduction on CT-based attenuation correction for PET imaging in the vicinity of metallic hip implants: a phantom study
177. The utility of PET imaging in depression.
178. The impact of FAP imaging in lung cancer and beyond: a new chapter
179. Abstract 150: Arterial Calcification and Neural Metabolic Activity: Assessing Neurovascular Status Through FDG and NaF PET/CT Imaging
180. Abstract 151: Age‐Related Increases in Carotid Artery Calcification: Insights from NaF PET/CT Imaging
181. Abstract 015: Pioneering NaF‐PET/CT Imaging for Early Detection of Atherosclerosis: Potential Implications for Neurointerventional Surgery
182. Abstract 149: Metabolic Neuroimaging in the Assessment of Cardiovascular Risk: A Regional FDG‐PET Analysis
183. Abstract 152: Exploring Age‐related Changes in Brain Metabolism among Individuals with Cardiovascular Risk Factors: An FDG‐PET Analysis
184. Advancements in dendritic cell vaccination: enhancing efficacy and optimizing combinatorial strategies for the treatment of glioblastoma
185. Bilateral Carotid Artery Molecular Calcification Assessed by [18F] Fluoride PET/CT: Correlation with Cardiovascular and Thromboembolic Risk Factors
186. Aging and Cerebral Glucose Metabolism: 18F-FDG-PET/CT Reveals Distinct Global and Regional Metabolic Changes in Healthy Patients
187. Utility of a simplified [18F] sodium fluoride PET imaging method to quantify bone metabolic flux for a wide range of clinical applications
188. Global brain glucose uptake on 18F-FDG-PET/CT is influenced by chronic cardiovascular risk
189. Magnetic resonance imaging-based partial volume-corrected 18F-sodium fluoride positron emission tomography in the femoral neck
190. Cognitive Impairment and Dementias
191. Diagnosis and Monitoring of Osteoporosis With 18F-Sodium Fluoride PET: An Unavoidable Path for the Foreseeable Future
192. Novel Quantitative PET Techniques for Clinical Decision Support in Oncology
193. Applications of PET Imaging in the Evaluation of Musculoskeletal Diseases Among the Geriatric Population
194. The Role of PET in Evaluating Atherosclerosis: A Critical Review
195. Diagnostic Role of Fluorodeoxyglucose PET in Breast Cancer: A History to Current Application
196. Characterization of the Electroanatomic Substrate in Cardiac Sarcoidosis: Correlation With Imaging Findings of Scar and Inflammation
197. Suboptimal Sensitivity and Specificity of PET and Other Gross Imaging Techniques in Assessing Lymph Node Metastasis
198. Glucose-6-phosphatase Expression–Mediated [18F]FDG Efflux in Murine Inflammation and Cancer Models
199. Global disease score (GDS) is the name of the game!
200. Diagnostic manifestations of total hemispheric glucose metabolism ratio in neuronal network diaschisis: diagnostic implications in Alzheimer’s disease and mild cognitive impairment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.